John Arlotta has joined General Atlantic as a special partner, with a focus on the healthcare sector. Arlotta is former chairman and CEO of Coram Inc. and NeighborCare Inc.
General Atlantic LLC (“GA”), a leading global growth equity firm, announced today that John Arlotta, former Chairman and CEO of Coram Inc. and NeighborCare Inc., has joined the firm as a Special Advisor. In this role, Mr. Arlotta will support GA’s active, value-added approach to partnering with leading growth companies in the healthcare sector.
Mr. Arlotta joins GA’s global network of healthcare-focused current and former Special Advisors, which includes Dr. Mark McClellan, former Administrator of the Centers for Medicare and Medicaid Services; Brent Saunders, formerly of Schering Plough and now CEO of Bausch & Lomb; and Tracy Bahl, former CEO of Uniprise and the current Executive Chairman of Emdeon. GA’s Special Advisor network consists of highly experienced senior executives who work closely with GA’s investment professionals in identifying new investment opportunities and in providing deep industry and operational expertise to GA’s portfolio companies.
General Atlantic has been active in the global healthcare sector for nearly three decades. GA’s recent investments include Emdeon, a leading provider of healthcare transaction services; Qualicorp, a leading Brazilian provider of diversified insurance brokerage and benefits administration services; and amedes Group, one of the largest German clinical lab groups, among others.
Jonathan Korngold, head of General Atlantic’s Global Healthcare Team, said, “John brings unparalleled insight and experience in the area of specialty provider services, which represent some of the most attractive subsectors in healthcare. We are excited to welcome him to the GA team in this important role.”
Mr. Arlotta said, “I look forward to actively supporting the GA Healthcare Team in evaluating the latest industry trends on a global basis. General Atlantic has a long and successful history supporting healthcare companies, and GA’s focus on global growth is an important differentiating factor in today’s environment. I am also excited to work closely with GA’s portfolio companies on their future growth initiatives.”
Prior to joining General Atlantic, Mr. Arlotta served as Chairman, President and CEO of Denver based Coram Inc, a privately held provider of home infusion and specialty pharmacy services with $500 million in revenues. The company merged with Apria Healthcare in December, 2008. Prior to Coram, he served as Chairman and CEO of NeighborCare Inc., a Baltimore based public company (NASDAQ:NCRX) with annual revenues of $1.6 billion. NeighborCare was in the business of providing pharmaceutical products and services to nursing homes. He joined NeighborCare in July, 2003 and took the company public in December of that year. Mr. Arlotta has also served as President and Chief Operating Officer of Caremark Rx and as Chairman, President, and CEO of HealthCall Corporation.
Mr. Arlotta is a graduate of the University of Notre Dame and is a retired U.S. Army Reserve Captain.
About General Atlantic
General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. GA combines a collaborative global approach, sector specific expertise, long-term investment horizon and a deep understanding of growth drivers to partner with great management and build exceptional businesses worldwide. Established in 1980, GA manages approximately $15 billion in capital and has more than 75 investment professionals based in Greenwich, New York, Palo Alto, London, Düsseldorf, Hong Kong, Beijing, Mumbai and São Paulo. For further information and a listing of GA’s public and private portfolio companies see www.generalatlantic.com.